Corteva Proxy Reveals $12.6M CEO Pay, 7% Stock Return for 2025
0h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
cortevachuck-magroexecutive-compensation
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Corteva Inc. filed its definitive proxy statement (DEF 14A) with the SEC on 1 June 2026, detailing executive compensation and governance matters for the upcoming annual shareholder meeting. The filing, sourced from investing.com, reveals that CEO Chuck Magro received total compensation of $12.6 million for the 2025 fiscal year, a period during which Corteva's stock delivered a total shareholder return of 7.1%. The proxy also shows the company's three-year cumulative TSR at 40.3%, outpacing the S&P 500's 20.7% return over the same period. Investors will vote on director elections, executive pay, and auditor ratification at the annual meeting scheduled for later this month.
Executive compensation remains in sharp focus for investors amid broader market volatility and rising operational costs in the agricultural sector. The most recent Federal Reserve Summary of Economic Projections points to a 'higher for longer' interest rate environment, which increases the cost of capital and places pressure on corporate performance metrics tied to incentive plans. Corteva's filing arrives as agribusiness peers like Bayer and Syngenta face renewed activist pressure over capital allocation and strategic direction.
A historical comparable is the 2022 proxy season, when Corteva's then-CEO Jim Collins received $16.7 million in total compensation following a year of 27% stock appreciation. The subsequent moderation in pay relative to stock performance reflects an evolving dialogue between boards and large institutional shareholders on pay-for-performance alignment. The current catalyst is the annual meeting cycle itself, a mandated event that forces a transparent accounting of leadership rewards against delivered outcomes.
Changing dynamics in global crop protection and seed markets have also triggered this scrutiny. Commodity price fluctuations, regulatory shifts in Europe concerning pesticide use, and ongoing consolidation among farm retailers directly impact Corteva's top-line growth and margin targets. These factors form the backdrop against which the board's compensation committee set the 2025 pay packages now subject to a non-binding shareholder vote.
Corteva's 2025 executive compensation data shows specific dollar values and performance metrics. CEO Chuck Magro's $12.6 million package comprised a $1.4 million base salary, a $2.3 million cash bonus, and $8.6 million in stock and option awards. The annual incentive plan was funded at 136% of target, reflecting the achievement of key financial and operational goals. For comparison, CFO David Anderson received total compensation of $5.8 million for the same fiscal year.
| Metric | 2025 Value | 2024 Value | Change |
|---|---|---|---|
| CEO Total Compensation | $12.6M | $14.1M | -10.6% |
| Annual TSR | 7.1% | 15.4% | -8.3 pp |
| 3-Year Cumulative TSR | 40.3% | 32.5% | +7.8 pp |
Corteva's 7.1% total shareholder return for 2025 lagged behind the S&P 500's 11.2% return but outperformed the iShares MSCI Global Agriculture Producers ETF's 5.8% return. The company's net sales for the year were reported at $17.9 billion. The proxy indicates that 89% of Magro's target compensation is variable and tied to performance, a structure designed to align executive interests with those of long-term shareholders.
The proxy data confirms a tightening link between pay and medium-term performance at Corteva, a positive signal for governance-focused funds. Second-order effects could include increased scrutiny on peers like Bayer (BAYN.DE) and FMC Corporation (FMC), where compensation structures may appear less aligned with TSR. Fertilizer producers Nutrien (NTR) and CF Industries (CF) could see indirect pressure as the agricultural input sector's performance metrics are compared.
A key limitation of the analysis is that the reported compensation reflects grant-date values for equity awards, not realized pay. The ultimate value Magro receives depends entirely on Corteva's future stock price, which is subject to volatile crop prices and weather patterns. The counter-argument is that a 7.1% annual return may not justify an eight-figure pay package, especially when base salaries are already well above median industry pay.
Positioning data from recent 13F filings shows that large asset managers like Vanguard and BlackRock have maintained or slightly increased their stakes in Corteva. Flow tracking suggests some hedge funds have taken tactical short positions in the options market ahead of the shareholder meeting, betting on potential governance-related volatility. The 'Say on Pay' vote will be the primary channel for institutional sentiment.
The immediate catalyst is Corteva's 2026 Annual Meeting of Stockholders, where the advisory vote on executive compensation will be tallied. A vote below 70% in favor would signal significant shareholder discontent and likely prompt engagement from the board's compensation committee. The next major earnings report is scheduled for late July 2026, which will provide the first substantive update on Q2 performance and full-year guidance.
Key levels to watch include Corteva's 200-day moving average, currently around $55.20, which has served as dynamic support throughout 2025. A sustained break below this level on high volume could indicate a shift in institutional confidence following the proxy details. On the upside, resistance is evident near the $60.00 psychological barrier, a level the stock has tested but not definitively breached in the last six months.
Investors should also monitor the USDA's June 30 Acreage Report for 2026 crop planting intentions, a major driver for seed and crop protection demand. Any significant deviation from expectations for corn and soybean acres will directly impact revenue projections for Corteva's seed segment. The outcome of the U.S. presidential election could also bring regulatory changes affecting agricultural chemical approvals.
A definitive proxy statement is an SEC-required document that provides shareholders with information necessary to vote on corporate matters at an annual or special meeting. For Corteva, the DEF 14A details the biographies of director nominees, the company's executive compensation philosophy and exact figures, and descriptions of shareholder proposals. It also discloses potential conflicts of interest and the board's committee structure. This document is distinct from the annual 10-K report, which focuses on audited financial results and business operations.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.